CAR- T and also cellular gene treatments are too costly

.Nature Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing as well as technology transactions can supply mobile gene therapies at an economical expense to patients all over the planet.